Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
July 14, 2026

[vc_row][vc_column][vc_single_image image="69243" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Glioblastoma (GBM) is the most aggressive form of brain cancer with a uniformly fatal diagnosis, limited treatment options, and a median survival of less than two years.   Although chimeric antigen receptor (CAR)-T cell immunotherapy has revolutionized the treatment of certain cancers,...

, ,

by
Blog
February 4, 2025

[vc_row][vc_column width="2/3"][vc_column_text css=""] The Headaches That Changed Everything In June 2001, Jodi Novak was living a normal, healthy life when severe migraines started disrupting her days. She instinctively knew something wasn’t right. Despite initial skepticism from her doctor, Jodi insisted on an MRI, suspecting that her headaches...

, ,

by
Blog
January 30, 2025

[vc_row][vc_column][vc_single_image image="63063" img_size="full" alignment="center" css=""][vc_column_text css=""]NFCR-supported researcher Dr. Rakesh K. Jain of Massachusetts General Hospital Cancer Center continues to make breakthroughs against some of the most difficult-to-treat cancers. In a recent study published in PNAS: Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma,...

, , , ,

by
Blog
June 25, 2024

[vc_row][vc_column width="1/3"][vc_single_image image="61586" img_size="full" alignment="center" css=""][/vc_column][vc_column width="2/3"][vc_column_text css=""]Twenty years ago, Carmen Rice was told to get her affairs in order, she was diagnosed with the deadliest form of brain cancer, glioblastoma. At the time, she was told she had about 6 months to live. In...

, , , ,

by
Blog
April 26, 2024

[vc_row][vc_column][vc_single_image image="60558" img_size="full" alignment="center"][vc_column_text]The National Foundation for Cancer Research is thrilled to congratulate Dr. Rakesh K. Jain, the A.W. Cook Professor of Radiation Oncology (Tumor Biology) and Director of the E.L. Steele Laboratory, on his achievement of being named the 2023 Proceedings of the National...

, , , ,

by
Blog
May 9, 2023

[vc_row][vc_column][vc_row_inner css=".vc_custom_1683656310062{padding-top: 15px !important;padding-right: 15px !important;padding-bottom: 15px !important;padding-left: 15px !important;background-color: #cccccc !important;}"][vc_column_inner width="1/3"][vc_single_image image="58010" img_size="full" alignment="center" onclick="link_image"][/vc_column_inner][vc_column_inner width="2/3"][vc_empty_space height="52px"][vc_column_text]Tom & Bernadette, November 2018 in Cienfuegos Cuba Mountain Park. “It was here first symptoms appeared but we did not know it. It was a rocky path...

, , , , ,

by
Media Coverage
July 21, 2022

[vc_row][vc_column][vc_single_image image="51753" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine...

, , , , ,

by
Media Coverage
April 22, 2022

[vc_row][vc_column][vc_column_text css=""][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Approximately 15,000 Americans will be diagnosed with glioblastoma this year. Although considered a rare cancer, doctors are seeing an increase in cases of the aggressive and deadly brain cancer that’s notoriously hard to treat. A local organization that’s helping enroll brain cancer patients in...

, , , ,

by
Blog, GBM Agile
April 21, 2022

[vc_row][vc_column][vc_single_image image="49165" img_size="full" alignment="center"][vc_column_text]On Wednesday, April 20, 2022, National Foundation for Cancer Research (NFCR) CEO Sujuan Ba and Scientific Board Chairman Web Cavenee joined NBC4 Washington’s Doreen Gentzler to talk about the passing of beloved journalist Wendy Rieger. Rieger passed on Saturday, April 16, 2022, after a battle...

, , , ,